SPNE News and Press, SeaSpine Holdings Corporation From 08/02/22

The following slide deck was published by SeaSpine Holdings Corporation in conjunction with their 2022 Q2 earnings call. For further details see: SeaSpine Holdings Corporation 2022 Q2 - Results - Earnings Call Presentation

SeaSpine press release ( NASDAQ: SPNE ): Q2 GAAP EPS of -$0.38 (vs. -$0.16 Y/Y) misses by $0.03 . Revenue of $56.3M (+18.6% Y/Y) beats by $1.97M . FY22 revenue is now expected to be in the range of $234M to $236M. This compares to previous revenue guidance of $...

CARLSBAD, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today second quarter financial results for the three-months ended June 30, 202...

CARLSBAD, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Meridian Anterior Lumbar Interbody Sys...

CARLSBAD, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the Company will present at the Canaccord Genuity 42 nd Annual ...

CARLSBAD, Calif., July 20, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release second quarter financial results after the close of...

SeaSpine ( NASDAQ: SPNE ) said Tuesday it amended its credit facility to extend its maturity date to Jul. 27, 2025 from Jul. 27, 2022. SPNE also has the option to increase the existing $30M borrowing limit by up to an additional $10M. "The additional liquidity provided...

CARLSBAD, Calif., July 19, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it has amended its credit facility with Wells Fargo Bank, N.A. The ...

It can be a lot of fun buying stocks trading in the single digits. While there are a lot of bad companies down in the cheap seats, sometimes you can find some amazing bargains. Our roundtable has found three really cool biotech stocks trading under $10 a share. Here's why we like SeaS...

SeaSpine holdings has continued to deliver a series of operating losses over the past two years to date. Investors have punished the stock to price in more systematic risks, overlooking idiosyncratic risk drivers. The company's delivered a lack of incremental value in FCF/share an...